Get the Weekly Intelligence Brief — top committee picks every Sunday.

CL vs UTI

Colgate-Palmolive vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
CL
Colgate-Palmolive
69
Insufficient Data
VS
UTI
Universal Technical Institute, Inc.
53
Watch
MetricCLUTI
AI Score 69 53
Price $92.32 $25.56
P/E Ratio 36.29× 40.60×
ROE 3948.1% 19.2%
Revenue Growth YoY
Gross Margin 60.4% 61.5%
Debt / Equity 33.29× 1.04×
Dividend Yield 2.3% 0.0%
RSI (14) 56.5 20.6
Beta 0.322 1.236
Expected Upside +1.1%

AI Committee View

Current Innellis committee reasoning for CL versus UTI.
CL leads by 16 points.

CL scores 69/100 (Insufficient Data) versus UTI at 53/100 (Watch).

CL Committee View
100% agreement
3 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • Risk/reward is unfavorable: 2.5% downside vs 1.1% upside.
UTI Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 37.4 is moderate-to-rich — Value
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • EPS declining -25.9% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CL Full Analysis UTI Full Analysis